Claire L. Vale
About
Claire L. Vale is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology.
According to data from OpenAlex, Claire L. Vale has authored 56 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 11 papers in Oncology. Recurrent topics in Claire L. Vale's work include Prostate Cancer Treatment and Research (13 papers), Meta-analysis and systematic reviews (10 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). Claire L. Vale is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Meta-analysis and systematic reviews (10 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). Claire L. Vale collaborates with scholars based in United Kingdom, United States and France. Claire L. Vale's co-authors include Jayne F. Tierney, Paul Symonds, Ruth E. Langley, Larysa Rydzewska, Fay Cafferty, C. Coyle, Mahesh Parmar, Lesley Stewart, David J. Fisher and Sarah Burdett and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.
In The Last Decade
Claire L. Vale
55 papers receiving 4.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Claire L. Vale United Kingdom | 25 | 2.2k | 1.3k | 996 | 645 | 508 | 56 | 4.4k | ||
| Eric Wallen United States | 43 | 2.8k 1.3× | 2.0k 1.6× | 922 0.9× | 1.3k 2.1× | 1.2k 2.3× | 179 | 5.6k | ||
| Cheryl T. Lee United States | 41 | 3.8k 1.7× | 1.2k 0.9× | 1.2k 1.2× | 1.6k 2.4× | 830 1.6× | 124 | 5.0k | ||
| Thomas J. Guzzo United States | 34 | 1.6k 0.8× | 1.6k 1.3× | 594 0.6× | 685 1.1× | 587 1.2× | 238 | 3.6k | ||
| Luis Martínez‐Piñeiro Spain | 26 | 2.3k 1.0× | 741 0.6× | 451 0.5× | 1.1k 1.7× | 529 1.0× | 161 | 3.5k | ||
| William T. Lowrance United States | 36 | 1.5k 0.7× | 2.4k 1.9× | 744 0.7× | 469 0.7× | 1.0k 2.0× | 116 | 4.0k | ||
| Matthew J. Resnick United States | 32 | 1.8k 0.8× | 2.2k 1.7× | 984 1.0× | 771 1.2× | 405 0.8× | 117 | 4.3k | ||
| Scott M. Gilbert United States | 29 | 1.6k 0.8× | 951 0.7× | 1.0k 1.0× | 604 0.9× | 412 0.8× | 152 | 3.3k | ||
| Karim Chamie United States | 34 | 2.5k 1.2× | 1.7k 1.3× | 1.3k 1.3× | 583 0.9× | 1.4k 2.7× | 183 | 5.1k | ||
| Robert Abouassaly United States | 31 | 1.4k 0.7× | 2.1k 1.7× | 495 0.5× | 398 0.6× | 864 1.7× | 189 | 3.5k | ||
| Gabe S. Sonke Netherlands | 42 | 2.0k 0.9× | 1.7k 1.4× | 4.2k 4.2× | 387 0.6× | 1.1k 2.2× | 314 | 8.2k |
Countries citing papers authored by Claire L. Vale
Since
Specialization
Citations
This map shows the geographic impact of Claire L. Vale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire L. Vale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire L. Vale more than expected).
Fields of papers citing papers by Claire L. Vale
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Claire L. Vale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire L. Vale. The network helps show where Claire L. Vale may publish in the future.
Co-authorship network of co-authors of Claire L. Vale
This figure shows the co-authorship network connecting the top 25 collaborators of Claire L. Vale. A scholar is included among the top collaborators of Claire L. Vale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire L. Vale. Claire L. Vale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fisher, David J., Claire L. Vale, Larysa Rydzewska, et al.. (2025). Which patients with metastatic hormone-sensitive prostate cancer (mHSPC) benefit more from androgen receptor pathway inhibitors (ARPIs)? STOPCAP meta-analyses of individual participant data (IPD).. Journal of Clinical Oncology. 43(5_suppl). 20–20.
2.
Gurusamy, Kurinchi Selvan, Jeffrey Leung, Claire L. Vale, et al.. (2024). Hyperthermic intraoperative peritoneal chemotherapy and cytoreductive surgery for people with peritoneal metastases: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 28(51). 1–139.
3.
Wattar, Bassel H. Al, Ewelina Rogozińska, Claire L. Vale, et al.. (2024). Effectiveness and safety of menopause treatments: pitfalls of available evidence and future research need. Climacteric. 27(2). 154–158.
4.
Fisher, David J., Sarah Burdett, Claire L. Vale, Ian R. White, & Jayne F. Tierney. (2022). Duplicated network meta-analysis in advanced prostate cancer: a case study and recommendations for change. Systematic Reviews. 11(1). 274–274.
5.
Godolphin, Peter J., David J. Fisher, Lindsay R. Berry, et al.. (2022). Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis. PLoS ONE. 17(7). e0270668–e0270668.
6.
Vale, Claire L., David J. Fisher, Peter J. Godolphin, et al.. (2022). Defining more precisely the effects of docetaxel plus ADT for men with mHSPC: Meta-analysis of individual participant data from randomized trials.. Journal of Clinical Oncology. 40(16_suppl). 5070–5070.
7.
Tierney, Jayne F., David J. Fisher, Claire L. Vale, et al.. (2021). A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials. PLoS Medicine. 18(5). e1003629–e1003629.
8.
Rogozińska, Ewelina, Elizabeth Gargon, Rocío Olmedo‐Requena, et al.. (2020). Methods used to assess outcome consistency in clinical studies: A literature-based evaluation. PLoS ONE. 15(7). e0235485–e0235485.
9.
Gafos, Mitzy, Annabelle South, Bec Hanley, et al.. (2020). “PROUD to have been involved”: an evaluation of participant and community involvement in the PROUD HIV prevention trial. Research Involvement and Engagement. 6(1). 13–13.
10.
South, Annabelle, Julia Bailey, Mahesh Parmar, & Claire L. Vale. (2019). Effectiveness and acceptability of methods of communicating the results of clinical research to lay and professional audiences: protocol for a systematic review. Systematic Reviews. 8(1). 150–150.
11.
Vale, Claire L., David J. Fisher, Ian R. White, et al.. (2018). What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis. Annals of Oncology. 29(5). 1249–1257.
12.
Vale, Claire L., David J. Fisher, Jayne F. Tierney, et al.. (2017). Re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002. European Urology. 73(3). e49–e50.
13.
Vale, Claire L., David J. Fisher, James R. Carpenter, et al.. (2017). What are the optimal systemic treatments for men with metastatic, hormone-sensitive prostate cancer? A STOPCaP systematic review and network meta-analysis. Annals of Oncology. 28. v620–v620.
14.
Vale, Claire L., Sarah Burdett, Larysa Rydzewska, et al.. (2015). Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data. The Lancet Oncology. 17(2). 243–256.
15.
Vale, Claire L., et al.. (2015). Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study. BMJ. 350(mar06 6). h1088–h1088.
16.
Vale, Claire L., Jayne F. Tierney, & Sarah Burdett. (2013). Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews. BMJ. 346(apr22 1). f1798–f1798.
17.
Vale, Claire L., Lindsay C Thompson, Claire Murphy, Silvia Forcat, & Bec Hanley. (2012). Involvement of consumers in studies run by the Medical Research Council Clinical Trials Unit: Results of a survey. Trials. 13(1). 9–9.
18.
Vale, Claire L., et al.. (2012). Evaluation of patient involvement in a systematic review and meta-analysis of individual patient data in cervical cancer treatment. Systematic Reviews. 1(1). 23–23.
19.
Vale, Claire L., Jayne F. Tierney, David J. Fisher, et al.. (2011). Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis. Cancer Treatment Reviews. 38(6). 618–625.
20.
Vale, Claire L.. (2006). Adjuvant chemotherapy for invasive bladder cancer (individual patient data). Cochrane Database of Systematic Reviews. 2011(4). CD006018–CD006018.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Eric Wallen Breakdown of academic impact, for papers by Cheryl T. Lee Breakdown of academic impact, for papers by Thomas J. Guzzo Breakdown of academic impact, for papers by Luis Martínez‐Piñeiro Breakdown of academic impact, for papers by William T. Lowrance Breakdown of academic impact, for papers by Matthew J. Resnick Breakdown of academic impact, for papers by Scott M. Gilbert Breakdown of academic impact, for papers by Karim Chamie Breakdown of academic impact, for papers by Robert Abouassaly Breakdown of academic impact, for papers by Gabe S. Sonke